BURGESS MICHAEL F. (Head of Research & Development) reported 1 transaction at SPRINGWORKS THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/20/2022ACC: 0001104659-22-081241
Officer· Head of Research & Development
Since May 2021
-3.10K
Net shares
Net seller
$88.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.10K
Price / share
$28.47
Trade value
$88.34K
% of position
5.9%
7/18/2022
52.69K→49.58K
Total
Net shares
−3.10K
Net value
-$88.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/18/2022 | F · Tax Withholding | −3.10K | $28.47 | $88.34K | 5.9% | 52.69K | 49.58K |
| Total | −3.10K | -$88.34K | ||||||
Derivative Transactions0
No derivative transactions reported